2019
DOI: 10.1002/ccr3.1947
|View full text |Cite
|
Sign up to set email alerts
|

PKD1 mutation may epistatically ameliorate nephronophthisis progression in patients with NPHP1 deletion

Abstract: Key Clinical Message We report a patient with adult‐onset nephronophthisis (NPHP) that was identified a homozygous full gene deletion of NPHP1 and a heterozygous PKD1 mutation. We suggest that the PKD1 mutation may have epistatically ameliorated NPHP disease progression and that the screening of larger cohorts for similar possible epistatic effects is needed.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
4
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
2
1

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(5 citation statements)
references
References 25 publications
0
4
1
Order By: Relevance
“…For NPHP patients, no modifier gene has been identified. However, a recent case report showed that PKD1 mutation might epistatically ameliorate NPHP progression in patients with NPHP1 deletion [23]. In our case, no such NPHP-modifier variant was observed.…”
Section: Discussioncontrasting
confidence: 65%
“…For NPHP patients, no modifier gene has been identified. However, a recent case report showed that PKD1 mutation might epistatically ameliorate NPHP progression in patients with NPHP1 deletion [23]. In our case, no such NPHP-modifier variant was observed.…”
Section: Discussioncontrasting
confidence: 65%
“…Normalization of FBW7 levels restored renal function without a measurable effect on overall cystic index. Because disease progression in people with ADPKD and NPHP1 is milder compared to NPHP1 alone 41 , we speculate that similar effects will be seen in compound Pkd1/Nphp1 , Pkd1/Nphp4 , or Pkd1/Tmem237 mice.…”
Section: Discussionmentioning
confidence: 82%
“…The copyright holder for this preprint this version posted March 3, 2024. ; https://doi.org/10.1101/2024.02.29.582788 doi: bioRxiv preprint measurable effect on overall cystic index. Because disease progression in people with ADPKD and NPHP1 is milder compared to NPHP1 alone 41 , we speculate that similar effects will be seen in compound Pkd1/Nphp1, Pkd1/Nphp4, or Pkd1/Tmem237 mice.…”
Section: Discussionmentioning
confidence: 82%
“…Mutations in these genes are associated with autosomal recessive polycystic kidney disease, Bardet-Biedl syndrome (BBS), and Joubert syndrome. Although these are autosomal recessive diseases, heterozygous point mutations in the genes may have had some effect on the homozygous NPHP1 mutation (11). Clin-Var (https://www.ncbi.nlm.nih.gov/clinvar/) reported that the mutation of IFT172 (p.Met560Val) is "likely benign," while that of BBS2 (p.Met645Thr) is of "uncertain significance" but had no data regarding the BBS1 mutation (p.Ile238Val).…”
Section: Discussionmentioning
confidence: 99%
“…Cases of NPH with NPHP1 gene mutations that show ESKD development in adulthood have rarely been reported ( 9 - 11 , 15 ). However, slowly progressive NPH, such as that observed in Case 2, may be underdiagnosed.…”
Section: Discussionmentioning
confidence: 99%